FIELD: organic chemistry, chemical technology.
SUBSTANCE: invention relates to a method for synthesis of N-methyl-N-{(1S)-1-phenyl-1-[(3S)-3-hydroxypyrrolidin-1-yl]ethyl}-2,2-diphenylacetamide. Method involves the following steps: (a) interaction of N-substituted derivative of phenylglycine of the formula (I): , wherein R means -OR1, -SR1; R1 means A, benzyl, unsubstituted phenyl or phenyl, biphenyl or naphthyl mono- or disubstituted with halogen atom, -OA or (C1-C6)-alkyl; A means linear or branched (C1-C6)-alkyl; M means hydrogen atom (H) or a cation chosen from group comprising alkaline metals, earth-alkaline metals, ammonium or alkylammonium with compound of the formula (II): , wherein R2 means H, A, or with acid-additive salt of compound of the formula (II) of acids HCl, HBr, HJ, H2SO4, H3PO4, or with organic carboxylic acid to obtain compound of the formula (III): , wherein R and R2 have above given values; (b) synthesized compound is converted to compound of the formula (IV): , by reduction reaction that is converted optionally to acid-additive salt of acids HCl, HBr, HJ, H2SO4, H3PO4, or to salt of organic carboxylic acid, and (c) synthesized compound of the formula (IV) is subjected for interaction with activated carboxylic acid of the formula (V): , wherein R4 means F, Cl, Br, J, -OA or -O-CO-A to yield compound of the formula (VI): , that is converted to a corresponding acid-additive salt using inorganic acid chosen from group comprising HCl, HBr, HJ, sulfuric acid, sulfamic acid, nitric acid, phosphoric acid, ortho-phosphoric acid or using organic acid.
EFFECT: improved method of synthesis.
7 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
N-METHYL-N-[(1S)-1-PHENYL-2((3S)-3-HYDROXYPYRROLIDINE-1-Y1)-ETHYL]-2,2-DIPHENYLACETAMIDE | 1996 |
|
RU2174976C2 |
KAPPA-OPIOID AGONISTS FOR TREATMENT OF DIARRHEA-PREVAILING IRRITABLE BOWEL SYNDROME AND ALTERNATE IRRITABLE BOWEL SYNDROME | 2008 |
|
RU2441655C2 |
METHOD FOR TREATING INFLAMMATORY INTESTINAL DISEASES | 1996 |
|
RU2190401C2 |
ARYLACETAMIDES, METHOD OF PREPARING SAME, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2125041C1 |
KAPPA-OPIATE AGONISTS FOR TREATMENT OF URINARY BLADDER DISEASES | 2002 |
|
RU2307651C2 |
DERIVATIVES OF N-HETEROCYCLYLMETHYLMENZAMIDES, OBTAINMENT AND APPLICATION IN THERAPY | 2004 |
|
RU2346945C2 |
APPLICATION OF COMPOUNDINGS, EFFECTIVE AS SELECTIVE OPIATE RECEPTOR MODULATORS | 2003 |
|
RU2336871C2 |
N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
HETEROAROMATIC MODULATORS OF RETINOL-BOUND ORPHAN GAMMA RECEPTOR | 2017 |
|
RU2771280C2 |
SULTAM DERIVATIVES | 2010 |
|
RU2565752C2 |
Authors
Dates
2007-05-10—Published
1999-04-16—Filed